Invasive breast carcinoma - IARC

882. Fisher RA, Lawler SD, Ormerod MG,
Imrie PR, Povey S (1987). Flow cytometry
used to distinguish between complete and
partial hydatidiform moles. Placenta 8: 249-
256.
883. Fishman DA, Schwartz PE (1994).
Current approaches to diagnosis and
treatment of ovarian germ cell malignancies.
Curr Opin Obstet Gynecol 6: 98-104.
884. FitzGerald MG, Bean JM, Hegde SR,
Unsal H, MacDonald DJ, Harkin DP,
Finkelstein DM, Isselbacher KJ, Haber DA
(1997). Heterozygous ATM mutations do
not contribute to early onset of breast cancer.
Nat Genet 15: 307-310.
885. Fitzgibbons PL, Henson DE, Hutter RV
(1998). Benign breast changes and the risk
for subsequent breast cancer: an update
of the 1985 consensus statement. Cancer
Committee of the College of American
Pathologists. Arch Pathol Lab Med 122:
1053-1055.
886. Fitzgibbons PL, Page DL, Weaver D,
Thor AD, Allred DC, Clark GM, Ruby SG,
O'Malley F, Simpson JF, Connolly JL,
Hayes DF, Edge SB, Lichter A, Schnitt SJ
(2000). Prognostic factors in breast cancer.
College of American Pathologists
Consensus Statement 1999. Arch Pathol
Lab Med 124: 966-978.
887. Flagiello D, Gerbault-Seureau M,
Sastre-Garau X, Padoy E, Vielh P,
Dutrillaux B (1998). Highly recurrent
der(1;16)(q10;p10) and other 16q arm alterations
in lobular breast cancer. G e n e s
Chromosomes Cancer 23: 300-306.
888. Flanagan CW, Parker JR, Mannel RS,
Min KW, Kida M (1997). Primary endodermal
sinus tumor of the vulva: a case report
and review of the literature. G y n e c o l
Oncol 66: 515-518.
889. Flemming P, Wellmann A, Maschek H,
Lang H, Georgii A (1995). Monoclonal antibodies
against inhibin represent key markers
of adult granulosa cell tumors of the
ovary even in their metastases. A report of
three cases with late metastasis, being
previously misinterpreted as hemangiopericytoma.
Am J Surg Pathol 19: 927-
933.
890. Fletcher CD, Tsang WY, Fisher C, Lee
KC, Chan JK (1992). Angiomyofibroblastoma
of the vulva. A benign neoplasm distinct
from aggressive angiomyxoma. Am J Surg
Pathol 16: 373-382.
891. Fletcher JA, Pinkus JL, Lage JM,
Morton CC, Pinkus GS (1992). Clonal 6p21
rearrangement is restricted to the mesenchymal
component of an endometrial
polyp. Genes Chromosomes Cancer 5: 260-
263.
892. Flint A, Gikas PW, Roberts JA (1985).
Alveolar soft part sarcoma of the uterine
cervix. Gynecol Oncol 22: 263-267.
893. Flint A, Oberman HA (1984). Infarction
and squamous metaplasia of intraductal
papilloma: a benign breast lesion that may
simulate carcinoma. Hum Pathol 15: 764-
767.
894. Fogt F, Vortmeyer AO, Ahn G, De
Girolami U, Hunt RB, Daly T, Loda M (1994).
Neural cyst of the ovary with central nervous
system microvasculature. Histopathology 2 4 :
477-480.
895. Foote FW, Stewart FW (1946). A histologic
classification of carcinoma of the
breast. Surgery 19: 74-99.
896. Ford D, Easton DF, Bishop DT, Narod
SA, Goldgar DE (1994). Risks of cancer in
BRCA1-mutation carriers. Breast Cancer
Linkage Consortium. Lancet 343: 692-695.
897. Ford D, Easton DF, Peto J (1995).
Estimates of the gene frequency of BRCA1
and its contribution to breast and ovarian
cancer incidence. Am J Hum Genet 57:
1457-1462.
898. Ford D, Easton DF, Stratton M, Narod
S, Goldgar D, Devilee P, Bishop DT, Weber
B, Lenoir G, Chang-Claude J, Sobol H,
Teare MD, Struewing J, Arason A,
Scherneck S, Peto J, Rebbeck TR, Tonin P,
Neuhausen S, Barkardottir R, Eyfjord J,
Lynch H, Ponder BA, Gayther SA, Zelada-
Hedman M, Birch JM, Lindblom A, Stoppa-
Lyonnet D, Bignon Y, Borg A, Hamann U,
Haites N, Scott RJ, Maugard CM, Vasen H
(1998). Genetic heterogeneity and penetrance
analysis of the BRCA1 and BRCA2
genes in breast cancer families. The
Breast Cancer Linkage Consortium. Am J
Hum Genet 62: 676-689.
899. Ford D, Easton DF, Stratton M, Narod
S, Goldgar D, Devilee P, Bishop DT, Weber
B, Lenoir G, Chang-Claude J, Sobol H,
Teare MD, Struewing J, Arason A,
Scherneck S, Peto J, Rebbeck TR, Tonin P,
Neuhausen S, Barkardottir R, Eyfjord J,
Lynch H, Ponder BA, Gayther SA, Zelada-
Hedman M (1998). Genetic heterogeneity
and penetrance analysis of the BRCA1 and
BRCA2 genes in breast cancer families.
The Breast Cancer Linkage Consortium.
Am J Hum Genet 62: 676-689.
900. Foschini MP, Eusebi V (1998).
Carcinomas of the breast showing myoep -
ithelial cell differentiation. A review of the
literature. Virchows Arch 432: 303-310.
901. Foschini MP, Eusebi V, Tison V (1989).
Alveolar soft part sarcoma of the cervix
uteri. A case report. Pathol Res Pract 184:
354-358.
902. Foschini MP, Marucci G, Eusebi V
(2002). Low-grade mucoepidermoid carcinoma
of salivary glands: characteristic
immunohistochemical profile and evidence
of striated duct differentiation.
Virchows Arch 440: 536-542.
903. Foschini MP, Pizzicannella G, Peterse
JL, Eusebi V (1995). Adenomyoepithelioma
of the breast associated with low-grade
adenosquamous and sarcomatoid carcinomas.
Virchows Arch 427: 243-250.
904. Foulkes WD, Wong N, Brunet JS,
Narod SA (1998). BRCA mutations and sur -
vival in breast cancer. J Clin Oncol 16:
3206-3208.
905. Fox H, Agrawal K, Langley FA (1972).
The Brenner tumour of the ovary. A clinicopathological
study of 54 cases. J Obstet
Gynaecol Br Commonw 79: 661-665.
906. Fox H, Agrawal K, Langley FA (1975). A
clinicopathologic study of 92 cases of
granulosa cell tumor of the ovary with special
reference to the factors influencing
prognosis. Cancer 35: 231-241.
907. Fox H, Laurini RN (1988). Intraplacental
choriocarcinoma: a report of two cases. J
Clin Pathol 41: 1085-1088.
908. Fox H, Sen DK (1967). A Krukenberg
tumour of the uterine cervix. J Obstet
Gynaecol Br Commonw 74: 449-450.
909. Fox H, Wells M, Harris M, McWilliam
LJ, Anderson GS (1988). Enteric tumours of
the lower female genital tract: a report of
three cases. Histopathology 12: 167-176.
910. Frable WJ, Kay S (1968). Carcinoma of
the breast. Histologic and clinical features
of apocrine tumors. Cancer 21: 756-763.
911. Fracchia AA, Robinson D, Legaspi A,
Greenall MJ, Kinne DW, Groshen S (1985).
Survival in bilateral breast cancer. Cancer
55: 1414-1421.
912. Fraga M, Prieto O, Garcia-Caballero T,
Beiras A, Forteza J (1994). Myxoid
leiomyosarcoma of the uterine cervix.
Histopathology 25: 381-384.
913. Franceschi S, Dal Maso L, Arniani S,
Crosignani P, Vercelli M, Simonato L,
Falcini F, Zanetti R, Barchielli A, Serraino
D, Rezza G (1998). Risk of cancer other than
Kaposi's sarcoma and non-Hodgkin's lymphoma
in persons with AIDS in Italy.
Cancer and AIDS Registry Linkage Study.
Br J Cancer 78: 966-970.
914 . Franquemont DW, Frierson HF Jr.,
Mills SE (1991). An immunohistochemical
study of normal endometrial stroma and
endometrial stromal neoplasms. Evidence
for smooth muscle differentiation. Am J
Surg Pathol 15: 861-870.
915. Fraser JL, Raza S, Chorny K, Connolly
JL, Schnitt SJ (1998). Columnar alteration
with prominent apical snouts and secretions:
a spectrum of changes frequently
present in breast biopsies performed for
microcalcifications. Am J Surg Pathol 22:
1521-1527.
916. Frei KA, Kinkel K (2001). Staging
endometrial cancer: role of magnetic resonance
imaging. J Magn Reson Imaging 13:
850-855.
917. Friedman HD, Mazur MT (1991).
Primary ovarian leiomyosarcoma. An
immunohistochemical and ultrastructural
study. Arch Pathol Lab Med 115: 941-945.
918. Friedman LS, Gayther SA, Kurosaki T,
Gordon D, Noble B, Casey G, Ponder BA,
Anton-Culver H (1997). Mutation analysis
of BRCA1 and BRCA2 in a male breast cancer
population. Am J Hum Genet 60: 313-
319.
919. Friedrich EG Jr., Wilkinson EJ, Fu YS
(1980). Carcinoma in situ of the vulva: a
continuing challenge. Am J Obstet
Gynecol 136: 830-843.
920. Frisch M, Biggar RJ, Goedert JJ
(2000). Human papillomavirus-associated
cancers in patients with human immunodeficiency
virus infection and acquired
immunodeficiency syndrome. J Natl
Cancer Inst 92: 1500-1510.
921. Fritz A, Percy C, Jack A,
Shanmugaratnam K, Sobin LH, Parkin DM,
Whelan S (2000). International Classification
of Diseases for Oncology (ICD-O). 3rd
ed. World Health Organization: Geneva.
922. Frixen UH, Behrens J, Sachs M, Eberle
G, Voss B, Warda A, Lochner D, Birchmeier
W (1991). E-cadherin-mediated cell-cell
adhesion prevents invasiveness of human
carcinoma cells. J Cell Biol 113: 173-185.
923. Fujii H, Matsumoto T, Yoshida M,
Furugen Y, Takagaki T, Iwabuchi K, Nakata
Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M,
Hirose S, Shirai T (2002). Genetics of synchronous
uterine and ovarian endometrioid
carcinoma: combined analyses of loss
of heterozygosity, PTEN mutation, and
microsatellite instability. Hum Pathol 33:
421-428.
924. Fujii H, Szumel R, Marsh C, Zhou W,
Gabrielson E (1996). Genetic progression,
histological grade, and allelic loss in ductal
carcinoma in situ of the breast.Cancer Res
56: 5260-5265.
925. Fujii H, Yoshida M, Gong ZX,
Matsumoto T, Hamano Y, Fukunaga M,
Hruban RH, Gabrielson E, Shirai T (2000).
Frequent genetic heterogeneity in the
clonal evolution of gynecological carcinosarcoma
and its influence on phenotypic
diversity. Cancer Res 60: 114-120.
926. Fujita M, Enomoto T, Wada H, Inoue
M, Okudaira Y, Shroyer KR (1996).
Application of clonal analysis. Differential
diagnosis for synchronous primary ovarian
and endometrial cancers and metastatic
cancer. Am J Clin Pathol 105: 350-359.
927. Fujiwaki R, Yoshida M, Iida K, Ohnishi
Y, Ryuko K, Miyazaki K (1998). Epithelioid
leiomyosarcoma of the uterine cervix.
Acta Obstet Gynecol Scand 77: 246-248.
928. Fukunaga M (2001). Pseudoangiomatous
hyperplasia of mammary stroma: a
case of pure type after removal of fibroadenoma.
APMIS 109: 113-116.
929. Fukunaga M, Ishihara A, Ushigome S
(1998). Extrauterine low-grade endometrial
stromal sarcoma: report of three cases.
Pathol Int 48: 297-302.
930. Fukunaga M, Miyazawa Y, Ushigome S
(1997). Endometrial low-grade stromal sarcoma
with ovarian sex cord-like differentiation:
report of two cases with an immunohistochemical
and flow cytometric study.
Pathol Int 47: 412-415.
931. Fukunaga M, Nomura K, Endo Y,
Ushigome S, Aizawa S (1996). Carcino-sarcoma
of the uterus with extensive neuroectodermal
differentiation.
Histopathology 29: 565-570.
932. Fukunaga M, Nomura K, Ishikawa E,
Ushigome S (1997). Ovarian atypical
endometriosis: its close association with
malignant epithelial tumours. H i s t o -
pathology 30: 249-255.
933. Fukunaga M, Ushigome S (1993).
Malignant trophoblastic tumors: immunohistochemical
and flow cytometric comparison
of choriocarcinoma and placental
site trophoblastic tumors. Hum Pathol 24:
1098-1106.
934. Fukunaga M, Ushigome S (1997).
Myofibroblastoma of the breast with
diverse differentiations. Arch Pathol Lab
Med 121: 599-603.
935. Fukunaga M, Ushigome S, Fukunaga
M, Sugishita M (1993). Application of flow
cytometry in diagnosis of hydatidiform
moles. Mod Pathol 6: 353-359.
936. Fukushima M, Twiggs LB, Okagaki T
(1986). Mixed intestinal adenocarcinomaargentaffin
carcinoma of the vagina.
Gynecol Oncol 23: 387-394.
937. Fulop V, Mok SC, Genest DR, Gati I,
Doszpod J, Berkowitz RS (1998). p53, p21,
Rb and mdm2 oncoproteins. Expression in
normal placenta, partial and complete
mole, and choriocarcinoma. J Reprod
Med 43: 119-127.
938 . Fulop V, Mok SC, Genest DR, Szigetvari
I, Cseh I, Berkowitz RS (1998). c-myc, c-
erbB-2, c-fms and bcl-2 oncoproteins.
Expression in normal placenta, partial and
complete mole, and choriocarcinoma. J
Reprod Med 43: 101-110.
939. Funk KC, Heiken JP (1989). Papillary
cystadenoma of the broad ligament in a
patient with von Hippel-Lindau disease.
AJR Am J Roentgenol 153: 527-528.
940. Furuya M, Shimizu M, Nishihara H, Ito
T, Sakuragi N, Ishikura H, Yoshiki T (2001).
Clear cell variant of malignant melanoma
of the uterine cervix: a case report and
review of the literature. Gynecol Oncol 80:
409-412.
941. Gabbay-Moore M, Ovadia Y, Neri A
(1982). Accessory ovaries with bilateral
dermoid cysts. Eur J Obstet Gynecol
Reprod Biol 14: 171-173.
942. Gaber LW, Redline RW, Mostoufi-
Zadeh M, Driscoll SG (1986). Invasive partial
mole. Am J Clin Pathol 85: 722-724.
386 References